Primary |
Arrhythmia |
8.3% |
Arthritis |
8.3% |
Atrial Fibrillation |
8.3% |
Blood Cholesterol Increased |
8.3% |
Cardiac Disorder |
8.3% |
Diabetes Mellitus |
8.3% |
Hypertension |
8.3% |
Macular Degeneration |
8.3% |
Restless Legs Syndrome |
8.3% |
Sleep Disorder |
8.3% |
Ventricular Flutter |
8.3% |
Vitamin Supplementation |
8.3% |
|
Drug Interaction |
25.0% |
Middle Insomnia |
25.0% |
Road Traffic Accident |
25.0% |
Wrong Drug Administered |
25.0% |
|
Secondary |
Product Used For Unknown Indication |
24.9% |
Insomnia |
9.8% |
Attention Deficit/hyperactivity Disorder |
8.7% |
Ill-defined Disorder |
7.6% |
Sleep Disorder |
7.0% |
Drug Use For Unknown Indication |
5.0% |
Anxiety |
4.2% |
Nightmare |
4.2% |
Poor Quality Sleep |
3.9% |
Autism |
3.4% |
Seasonal Allergy |
3.4% |
Epilepsy |
2.8% |
Hallucination, Auditory |
2.5% |
Delirium |
2.2% |
Hypertension |
2.0% |
Depression |
1.7% |
Graft Versus Host Disease |
1.7% |
Mental Retardation |
1.7% |
Suicide Attempt |
1.7% |
Supplementation Therapy |
1.7% |
|
Wrong Drug Administered |
11.3% |
Multiple Drug Overdose |
8.8% |
Toxicity To Various Agents |
8.8% |
Weight Increased |
8.8% |
Completed Suicide |
6.3% |
Unresponsive To Stimuli |
5.0% |
Withdrawal Syndrome |
5.0% |
Wrong Patient Received Medication |
5.0% |
Cardiac Disorder |
3.8% |
Death |
3.8% |
Drug Interaction |
3.8% |
Intentional Drug Misuse |
3.8% |
Oedema |
3.8% |
Suicidal Ideation |
3.8% |
Urinary Bladder Rupture |
3.8% |
Visual Impairment |
3.8% |
Weight Decreased |
3.8% |
Aggression |
2.5% |
Drug Effect Decreased |
2.5% |
Hallucination |
2.5% |
|
Concomitant |
Product Used For Unknown Indication |
42.6% |
Insomnia |
7.1% |
Drug Use For Unknown Indication |
6.6% |
Pain |
5.5% |
Sleep Disorder |
5.5% |
Depression |
4.3% |
Attention Deficit/hyperactivity Disorder |
3.3% |
Hypertension |
3.2% |
Anxiety |
3.0% |
Gastrooesophageal Reflux Disease |
2.1% |
Prophylaxis |
1.9% |
Supplementation Therapy |
1.9% |
Rheumatoid Arthritis |
1.8% |
Crohn's Disease |
1.8% |
Vitamin Supplementation |
1.7% |
Asthma |
1.6% |
Osteoporosis |
1.5% |
Constipation |
1.5% |
Fibromyalgia |
1.5% |
Convulsion |
1.5% |
|
Vomiting |
8.9% |
Weight Increased |
8.9% |
Weight Decreased |
7.8% |
Insomnia |
5.9% |
Nausea |
5.8% |
Pain |
5.8% |
Product Quality Issue |
4.9% |
Death |
4.7% |
Drug Ineffective |
4.7% |
Somnolence |
4.7% |
Suicidal Ideation |
4.7% |
Off Label Use |
4.6% |
Rash |
4.4% |
Vision Blurred |
4.3% |
Wheezing |
3.7% |
Urinary Tract Infection |
3.6% |
Convulsion |
3.3% |
Flushing |
3.3% |
Tremor |
3.1% |
Headache |
3.0% |
|
Interacting |
Pain |
17.3% |
Insomnia |
13.5% |
Systemic Lupus Erythematosus |
11.5% |
Asthma |
7.7% |
Headache |
5.8% |
Hormone Replacement Therapy |
3.8% |
Lung Neoplasm Malignant |
3.8% |
Mania |
3.8% |
Muscle Spasms |
3.8% |
Pollakiuria |
3.8% |
Sleep Disorder |
3.8% |
Thyroid Disorder |
3.8% |
Urinary Incontinence |
3.8% |
Anxiety Disorder |
1.9% |
Bone Disorder |
1.9% |
Contraception |
1.9% |
Convulsion |
1.9% |
Encephalopathy |
1.9% |
Gastritis |
1.9% |
Gastrooesophageal Reflux Disease |
1.9% |
|
Dysphemia |
20.0% |
Uterine Disorder |
20.0% |
Vomiting |
20.0% |
Haemolytic Anaemia |
10.0% |
Insomnia |
10.0% |
Performance Status Decreased |
10.0% |
Pulmonary Oedema |
10.0% |
|